Literature DB >> 10676900

Experimental reinfection with homologous porcine reproductive and respiratory syndrome virus in SPF pigs.

I Shibata1, M Mori, S Yazawa.   

Abstract

The present examination was conducted to determine if the pigs infected with one strain of porcine reproductive and respiratory syndrome virus (PRRSV) would be protected against a subsequent homologous virus challenge. Sixteen 4-week-old SPF pigs were assigned to 2 experimental groups A and B. The pigs in group A were inoculated with 10(6.5) TCID50 of PRRSV by intranasal route. On 77 days post-inoculation (PI), pigs in groups A and B were similarly inoculated with same virus. After the secondary inoculation, the pigs in group A didn't show any clinical sign including pyrexia and reduction of white blood cell (WBC) number. Viremia was detected only on 3 days PI with low virus titer and any virus was not recovered from serum and tissues at the time of necropsy on 14 or 28 days PI. In contrast, pigs in group B showed pyrexia for 14 days and reduction of WBC number on 3 days PI. Viremia was detected between 3 and 28 days PI, and virus was isolated from several tissues of all pigs. These results indicate that previous exposure to PRRSV can prevent development of clinical signs and reduce virus proliferation in pigs after subsequent infection with the homologous PRRSV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10676900     DOI: 10.1292/jvms.62.105

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  5 in total

1.  Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.

Authors:  Xiuling Yu; Zhi Zhou; Zhen Cao; Jiajun Wu; Zhongqiu Zhang; Baiwan Xu; Chuanbin Wang; Dongmei Hu; Xiaoyu Deng; Wei Han; Xiaoxue Gu; Shuo Zhang; Xiaoxia Li; Baoyue Wang; Xinyan Zhai; Kegong Tian
Journal:  Clin Vaccine Immunol       Date:  2015-03-04

2.  Evaluation of the efficacy of an attenuated live vaccine against highly pathogenic porcine reproductive and respiratory syndrome virus in young pigs.

Authors:  Xue Leng; Zhenguang Li; Mingqi Xia; Yanliang He; Hua Wu
Journal:  Clin Vaccine Immunol       Date:  2012-06-13

3.  Molecular characterization of porcine reproductive and respiratory syndrome virus (PRRSv) identified from slaughtered pigs in northern Uganda.

Authors:  Peter Oba; Michel M Dione; Joseph Erume; Barbara Wieland; Christine Mutisya; Linnet Ochieng; Elizabeth A J Cook; Frank N Mwiine
Journal:  BMC Vet Res       Date:  2022-05-13       Impact factor: 2.792

4.  Experimental dual infection of specific pathogen-free pigs with porcine reproductive and respiratory syndrome virus and pseudorabies virus.

Authors:  I Shibata; S Yazawa; M Ono; Y Okuda
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2003-02

5.  Concurrent porcine circovirus type 2a (PCV2a) or PCV2b infection increases the rate of amino acid mutations of porcine reproductive and respiratory syndrome virus (PRRSV) during serial passages in pigs.

Authors:  Shuang-Hui Yin; Chao-Ting Xiao; Priscilla F Gerber; Nathan M Beach; Xiang-Jin Meng; Patrick G Halbur; Tanja Opriessnig
Journal:  Virus Res       Date:  2013-09-13       Impact factor: 3.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.